Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.
about
The host protein Staufen1 interacts with the Pr55Gag zinc fingers and regulates HIV-1 assembly via its N-terminusArchitecture and secondary structure of an entire HIV-1 RNA genomeComplex interactions of HIV-1 nucleocapsid protein with oligonucleotidesHuman cellular nucleic acid-binding protein Zn2+ fingers support replication of human immunodeficiency virus type 1 when they are substituted in the nucleocapsid proteinHuman immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integrationHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchHIV-1 reverse transcriptionThree-dimensional imaging of HIV-1 virological synapses reveals membrane architectures involved in virus transmission.Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry.The DNA repair genes XPB and XPD defend cells from retroviral infectionC-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA bindingCooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteinsDiscovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.Effect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity.Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.Modular organization and reticulate evolution of the ORF1 of Jockey superfamily transposable elements.Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response.Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implicationsKnockdown of the cellular protein LRPPRC attenuates HIV-1 infection.Host and viral determinants for MxB restriction of HIV-1 infection.Cofactors for human immunodeficiency virus type 1 cDNA integration in vitroDimeric RNA recognition regulates HIV-1 genome packaging.Single-molecule stretching studies of RNA chaperones.Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.Identification of a methylated oligoribonucleotide as a potent inhibitor of HIV-1 reverse transcription complex.Blocking premature reverse transcription fails to rescue the HIV-1 nucleocapsid-mutant replication defect.Single DNA molecule stretching measures the activity of chemicals that target the HIV-1 nucleocapsid protein.FRET analysis reveals distinct conformations of IN tetramers in the presence of viral DNA or LEDGF/p75.Investigating the cellular distribution and interactions of HIV-1 nucleocapsid protein by quantitative fluorescence microscopy.Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus.Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells.Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particlesThe next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers.Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1Construction and analysis of cells lacking the HMGA gene family.Single-molecule spectroscopic study of dynamic nanoscale DNA bending behavior of HIV-1 nucleocapsid protein.
P2860
Q24315925-EDA70A64-0ECE-4F6D-84F2-5BF2F03F9099Q24498349-6B19B406-5339-42D5-88FB-C2FFE81B4761Q24539163-71957003-99FF-4108-BFDA-671E817BA60CQ24682466-F798E7C0-7C2B-4641-A1FC-EA716D5225E7Q24684279-C25E33FF-ED07-4157-B3D5-986ED6EBC1EFQ26746070-052C9898-A1CC-45E4-9CFA-92F28B555715Q27023387-764A93D4-7661-46E8-B66C-7D1F1576C978Q30588474-DC208795-B6FB-45BC-B237-239E44AF8DC5Q33202469-9CA45C3A-9F09-4E37-87B8-809FEF375C23Q33236490-3BAEA927-A646-445F-987F-DDF147F9973BQ33581258-A64AE78C-F1E6-4725-9B84-7FCC4EE1637BQ33589910-A44F7187-CF0D-4108-8A9B-A214DEC5990AQ33707470-FAF21C73-C2F5-4BC1-946F-A777ADB73995Q33718048-7F7D9A69-FAB7-4429-93E4-BD36947BB65DQ33780620-F226B1E8-ABFA-4BAE-9273-5DF694D3BD68Q33788773-BAD2516F-1837-47EF-9121-12CEAB21D3E6Q33791156-CE73F73C-CD5D-4118-ACA5-27935F7BA3ADQ33997786-8594B678-0501-4C0E-B852-FCDF80145D10Q34012585-4543FF2D-BDE7-4FDA-BB7F-D7923C65AE15Q34237075-88FABB48-AFDF-4C7E-99B0-66C28F91F0B1Q34342115-46E843F0-1034-4872-8FC1-546AFC1C7984Q34422979-9ED68DA1-1446-4380-AB42-10F6C0C6B1DAQ34464329-E171C2E7-B6B2-4BFB-9C1B-88D8EDE2398FQ34649673-D1673702-3797-4182-BDE5-B72BF99CFCCCQ34775650-4C45D917-2AE1-4DC5-A4E3-DC7C46054D7CQ34976852-2B52E72A-7C16-48CA-9526-8A8FEA04A7C3Q35120765-B3AC18F4-0DF4-4FD3-9E01-37C875604F3CQ35122165-D37EBD5A-4189-4601-A17B-C56D7DDD118AQ35166620-E11CC92B-787F-4B15-977C-2CB7E09976ECQ35468454-B0C6E6CB-3CEB-41AE-A0A2-535574CAEFB1Q35568826-ECAF66AA-541C-4C35-A5A5-3D2BEA7270FCQ35704078-D20F69F6-28C9-43F0-9A15-57E79FD4A07EQ35785356-C7BDA835-2E2D-4EAA-B0C0-1CECD18B86A8Q35803032-BC2EE435-A8EF-4774-A14A-904059F7142AQ35857486-E044FF35-EB49-4490-9321-B60851AB9619Q35917148-946C2B0D-20AF-4836-8564-6E3D01EC1713Q35990587-F2C21307-D1B0-485E-B421-5BF1FFF80029Q36098898-04A9EAF7-BD2C-490C-B0CB-CF9DEEE99EBBQ36247428-6803A8ED-BDFB-4D69-9F4E-719AAF87E158Q36377116-09AC28D8-3BFC-4364-B35E-8CE3CB7F0099
P2860
Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@ast
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@en
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@nl
type
label
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@ast
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@en
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@nl
prefLabel
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@ast
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@en
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@nl
P2860
P1433
P1476
Human immunodeficiency virus t ...... f newly synthesized viral DNA.
@en
P2093
James S Buckman
William J Bosche
P2860
P304
P356
10.1128/JVI.77.2.1469-1480.2003
P407
P577
2003-01-01T00:00:00Z